September 28, 2016 9:46 PM ET


Company Overview of EpiCept Corporation

Company Overview

As of August 25, 2013, EpiCept Corporation was acquired by Immune Pharmaceuticals Ltd., in a reverse merger transaction. EpiCept Corporation, a specialty pharmaceutical company, focuses on the clinical development and commercialization of pharmaceutical products for the treatment of pain and cancer. The company develops AmiKet, a prescription topical analgesic cream that has completed Phase II clinical trials for the treatment of peripheral neuropathies. It also develops Azixa, an apoptosis inducer that is in Phase II clinical development for the treatment of brain cancer. In addition, the company is developing crolibulin, a novel small molecule vascular disruption agent and apoptosis induce...

777 Old Saw Mill River Road

Tarrytown, NY 10591

United States

Founded in 1993

4 Employees





Key Executives for EpiCept Corporation

EpiCept Corporation does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
20n Labs, Inc. United States
23andMe, Inc. United States
2C Tech Corporation, Inc. United States
3-V Biosciences, Inc. United States
3D Bio Holdings LLC United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Bloomberg L.P. United States
NYC2012, Inc. United States
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact EpiCept Corporation, please visit Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at